TIDMEBIV

RNS Number : 7552C

Eastbridge Investments PLC

30 June 2016

30 June 2016

Eastbridge Investments Plc

Preliminary Results for the year ended 31 December 2015

Eastbridge Investments Plc ("Eastbridge" or "Company") is pleased to present its results for the year ended 31 December 2015.

Results and Review of Business

The loss for the period was GBP432,000 (2014: restated loss GBP12,188,000) representing a loss per share of 0.24p (2014: Loss 20.30p).

On 9 January 2015, the Company held a general meeting at which the disposal of its former business and adoption of a new investing policy was approved by shareholders. The Company successfully raised over GBP400,000 through the issue of new equity to investors in order to progress its investing policy and identified a number of potential investment targets. However, it became apparent to the Directors that the likelihood of obtaining the additional financing required to complete any of these investments, for which approximately another GBP600,000 was needed was unlikely.

On the 30(th) October 2015, in light of the increasing difficulty in securing additional investment to enact the Company's existing investing policy, and in order to best generate returns, the Directors proposed and shareholders approved a new investing policy focussed on asset backed or insured equity and debt instruments which make regular cash payments, principally those used to fund retail finance in the form of secured and unsecured personal loans from the issuers of the securities being acquired. The Directors believed that this opportunity presented shareholders with a better chance of a return on their investment in the Company than the existing policy and thus adopted it. Following the general meeting, a placing raised GBP500,000 and these funds were invested in the Tranche B Helix Securitisation Fund, which yield 9.85% per annum. We were unable to conclude any further fund raising within the period.

Outlook

Under the AIM Rules for Companies, an investing company such as Eastbridge is required to either have fulfilled its investing policy or carried out a reverse acquisition within 12 months of the date upon which it became an investing company. Given the limited financial resources available to Eastbridge, the majority of which have been invested, the Company was not considered to have fulfilled its investing policy and it had not yet completed a reverse acquisition by the anniversary date. Pursuant to AIM Rule 15, shares in the Company were suspended from trading on 11(th) January 2016. At the same time we announced that we had agreed terms for the acquisition of Privilege Wealth Plc ("Privilege"). The acquisition of Privilege would constitute a reverse transaction under the AIM Rules for Companies and would be subject to approval by Eastbridge's shareholders in general meeting. Further to the completion of Heads of Agreement on 8 January 2016, negotiation and due diligence regarding the reverse acquisition of Privilege were ongoing and the Company made every effort to conclude the acquisition. However the complexities of the deal within the limited time window proved insurmountable and the board concurrently sought other possibilities to generate shareholder value.

On the 21 June 2016, the Company announced that it has now received an alternative proposal regarding the future of the Company. In light of the limited progress that has been made in respect of the acquisition of Privilege and the short time remaining until the Company is liable to be cancelled from trading on AIM, the directors have agreed with the owners of Privilege that following passing of the resolutions at the general meeting held on 24 June, 2016, negotiations with Privilege regarding the potential reverse transaction are terminated and that the Company is pursuing the alternative proposal. On the same day the outstanding warrants and warrant issuance programme with Peterhouse Corporate Finance and Helix Investment Management SLP were cancelled. As compensation for the cancellation of the 8.5 billion warrants subscribing for ordinary shares in Eastbridge previously held by Helix, they will receive a fee of GBP30,000. This fee will be settled from the fixed coupon due to the Company in respect of the GBP500,000 Tranche B Helix Securitisation Fund notes ("Helix Notes") acquired on 2 December 2015, which yield 9.85% per annum. In addition, Eastbridge has agreed that henceforth any coupon payment received in respect of the Helix Notes (over and above the aforementioned GBP30,000) will be reinvested in new further notes issued under the same programme. The Helix Notes are scheduled to be redeemed on 30 June 2020 but, as a result of these arrangements, until such time as redemption takes place the Company will not receive any cash distribution in respect of its holding.

Under the new terms being offered the Company will receive, upon shareholder approval to the revised investing policy, approximately GBP3.17 million of new investment which will be immediately deployed towards fulfilment of that revised investing policy. The funds will be invested in a range of low-risk equity and debt instruments issued by banks and other financial service providers that produce regular cashflow and this will be used as the cornerstone of the Company's investment portfolio. It is the current intention that further funds will be raised later in the year to add to the portfolio.

Presuming that the new investing policy is adopted at the general meeting on 6 July 2016, the placing completed and a range of new investments acquired the Company will apply to AIM Regulation for confirmation that, by holding approximately GBP3.6 million of securities spread across a range of issuers in accordance with its investing policy, it has satisfied its investing policy and thus trading in its ordinary shares, on AIM should resume.

I would like to thank shareholders for their continued patience.

Gregory Collier

Chairman

The directors present their strategic report for the year ended 31 December 2015.

Principal activity

In 2014, the principal activity of the company was that of an investing holding company for a group involved in the manufacture of lathes and machinery tools.

In October 2015 the company changed its principal business activity to be an investment company involved in asset backed or insured debt instruments which make regular cash payments, principally those offered to retail consumers in the form of secured and unsecured personal loans.

It has been classified as an Investing Company under AIM Rule 15.

Key performance indicators

The key performance indicators are set out below:

 
                             31 December   31 December 
                                    2015          2014 
--------------------------  ------------  ------------ 
Total assets                  GBP729,000    GBP106,000 
Net asset value per share          0.14p       (0.08)p 
Closing share price                0.38p          5.5p 
Market capitalisation       GBP1,623,000  GBP3,302,000 
--------------------------  ------------  ------------ 
 

Key risks and uncertainties

Currently the principal risk is that the Company is unable to find sufficient suitable investments to ensure compliance with the requirements of its listing on AIM.

Going Concern

As disclosed in the Chairman's statement, the Company plans to proceed with its new investment proposal which would provide sufficient funds to enable the Company to continue its operation and facilitate further investments for the foreseeable future. The Directors' new investment proposal is, however, subject regulation prescribed by AIM Rules on agreeing the company meeting its Investing Policy. If it is not possible for the Directors to realise their plans, over which there is significant uncertainty, the carrying value of the assets of the Company is likely to be impaired.

Based on the current forecast, the Company is likely to need additional funds within twelve months of the date of approval of this Annual Report in order to maintain its proposed work programme and levels of expenditure.

Dividends

The Directors do not recommend payment of a dividend for the year (2014: GBPnil). The loss is transferred to reserves.

Directors and Directors' interests

The Directors who served during the year and their interests in the Ordinary Shares in the Company are as follows:

 
                                             Ordinary       Ordinary 
                                             shares of      shares of 
                                            0.01p held     0.01p held 
                                                at             at 
                                            31 December    31 December 
                                               2015           2014 
----------------------------------------  -------------  ------------- 
 Mark Chapman (resigned 05.03.2015)          117,632          117,632 
 Roberto Lima (resigned 09.01.2015)             -              - 
 Hao Qiang (resigned 09.01.2015)             500,000        500,000 
 Gregory Collier (appointed 09.01.2015)         -              - 
 Stuart Black (appointed 05.03.2015,            -              - 
  resigned 29.07.2015) 
 Andrew Oswald (appointed 29.07.15)             -              - 
 Steven Hodgetts (appointed 30.10.15,           -              - 
  resigned 24.06.2016) 
 

Other significant shareholdings

As on 19(th) June 2016 the company had been notified of the following interests in its ordinary shares which represent 3% or more of the issued share capital of the company other than directors interests which is disclosed above.

 
                                     Number of      % 
                                       shares 
---------------------------------  ------------  ------ 
 Beaufort Nominees Limited          178,901,640   41.88 
 Philip McGinlay                    80,142,857    18.76 
 Paul Segal                         55,225,737    12.93 
 Wonder Employee Capital Limited    30,266,344    7.08 
 

Share capital

Details of issues of Ordinary Share capital during the year are set out in note 14.

Financial instruments and other risks

Details of the use of financial instruments by the Company are contained in note 16 of the financial statements.

Details of risks and uncertainties that affect the Company's business are given in the Strategic Report.

 
 STATEMENT OF COMPREHENSIVE INCOME 
  YEARED 31 DECEMBER 2015 
                                      Note             Restated 
                                                2015       2014 
                                             GBP'000    GBP'000 
 
 Administrative expenses                 6     (440)      (257) 
 
 Exceptional item                        5         -   (11,931) 
 
 
 Loss on operating activities                  (440)   (12,188) 
 
 Finance income                                    8          - 
 
 Loss before taxation                          (432)   (12,188) 
 
 
 Loss for the year                             (432)   (12,188) 
 
 
 Loss per share (pence) 
 
 Basic and diluted loss per share       13   (0.24p)   (20.30p) 
 
 
 
 

No separate statement of comprehensive income is provided as all income and expenditure is disclosed above.

 
 STATEMENT OF FINANCIAL POSITION 
  AS AT 31 DECEMBER 2015 
                                                                                  Restated 
                                                             2015                     2014 
                                    Note                  GBP'000                  GBP'000 
 Non-current assets 
 Investments - available 
  for sale                             8                      615                        - 
 
                                                              615                        - 
 
 Current assets 
 Other receivables                     9                        2                        2 
 Cash and cash equivalents            10                      112                      106 
 
                                                              114                      108 
 
 Total assets 
                                                              729                      108 
 
 Equity and reserves 
 Called-up share capital              14                    1,495                    1,501 
 Share premium account                                      9,566                    8,260 
  Share-based payment reserve                                 107                        - 
 Loan note equity reserve                                       -                       11 
 Profit and loss account                                 (10,550)                 (10,118) 
 
 
 Total equity                                                 618                    (346) 
 
 
 Non-current liabilities 
 Convertible loan notes               15                        -                       39 
 
                                                                -                       39 
 Current liabilities 
 Trade and other payables             11                      111                      415 
 
 
 Total liabilities                                            111                      454 
 
 
 Total equity and liabilities                                 729                      108 
 
 
 
 

The financial statements were approved by the board of directors and authorised for issue on 29 June 2016 and signed on its behalf by:

Gregory Collier

Chairman

 
 STATEMENT OF CHANGES IN EQUITY 
  YEARED 31 DECEMBER 2015 
                                                 Restated   Loan Note   Share-based 
                            Share       Share    Retained      Equity       payment 
                          Capital     Premium    Earnings     Reserve       reserve      Total 
                                                  Account 
                          GBP'000     GBP'000     GBP'000     GBP'000       GBP'000    GBP'000 
 
 At 1 January 
  2014                      1,451       8,260       2,070           -             -     11,781 
 
 Issue of share 
  capital                      50           -           -           -             -         50 
 Convertible 
  loan note                     -           -           -          11             -         11 
 Total comprehensive 
  loss for the 
  year                          -           -    (12,188)           -             -   (12,188) 
 
 At 31 December 
  2014                      1,501       8,260    (10,118)          11             -      (346) 
 
 Issue of share 
  capital                      27           -           -           -             -         27 
 Share premium                  -       1,273           -           -             -      1,273 
 Convertible 
  loan note                     -           -           -        (11)             -       (11) 
 Share-based 
  payment equity                -           -           -           -           107        107 
 Transfer of 
  shares to no 
  par value                  (33)          33           -           -             -          - 
 Total comprehensive 
  loss for the 
  year                          -           -       (432)           -             -      (432) 
 
 At 31 December 
  2015                      1,495       9,566    (10,550)           -           107        618 
                       ==========  ==========  ==========  ==========  ============  ========= 
 
 
 CASH FLOW STATEMENT 
  YEARED 31 DECEMBER 2015 
                                                                Restated 
                                               Year ended     Year ended 
                                              31 December    31 December 
                                                     2015           2014 
                                                  GBP'000        GBP'000 
 Cash flows from operating activities 
 Loss on operating activities                       (440)       (12,188) 
 Decrease/(increase) in trade and 
  other receivables                                     -            (2) 
 (Decrease)/increase in trade and 
  other payables                                    (189)            321 
 Exceptional item                                       -         11,806 
 Foreign exchange loss                                  -             26 
 
 Net cash inflow/(outflow) from 
  operating activities                              (629)           (37) 
 
 Cash flows from investing activities 
 Purchase of investments                            (500)              - 
 
 
 Net cash used in investing activities              (500)              - 
 
 
 Cash flows from financing activities 
 Proceeds from issue of ordinary 
  shares                                            1,020             50 
 Proceeds from loan                                   115             50 
 
 
 Net cash inflow from financing 
  activities                                        1,135            100 
 
 
 Net increase/(decrease) in cash 
  and cash equivalents                                  6             63 
 Cash and cash equivalents at beginning 
  of year                                             106             43 
 
 
 Cash and cash equivalents at end 
  of year                                             112            106 
 
 
 

NOTES TO THE COMPANY'S FINANCIAL STATEMENTS

YEARED 31 DECEMBER 2015

   1.            General information 

Eastbridge Investments Plc is a company incorporated in Jersey under the Companies (Jersey) Law 1991. The address of the registered office is given on page 1.

The principal activity of the company is that of an investment company.

These financial statements are rounded to the nearest thousand ('000).

   2.            Accounting policies 

Basis of preparation

These financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRSs"), as adopted by European Union, IFRIC Interpretations and in accordance with those parts of the Companies (Jersey) Law 1991, applicable to companies reporting under IFRS.

The Company has adopted all relevant standards effective for accounting periods beginning on or after 1 January 2014 with the exception of IFRS 10 Consolidated Financial Statements. Win Yu International Investments Company Limited ("WYIC") and Jiangsu Qihang CNC Machinery Tools Co., Ltd ("JSQH") were subsidiary undertakings of the Company from July 2011 until their disposal on 9 January 2015. The disposal of the subsidiary companies was put through the 2014 accounts and were reflected under discontinued activities. As these companies were the only subsidiaries, Group accounts have not been prepared and the accounts presented herein, both for the current period and the comparative period, represent those of the Company only.

The comparative figures in the income statement and statement of financial position for the year ended 31 December 2014 have been restated to include an amount of GBP125,000 due to Wonder Employee Capital Limited at 31 December 2014 which was settled by the issue of 30,266,344 shares at 0.413p per share in January 2015.

Going concern

At the year end the company had net assets of GBP618,000 (2014: net liabilities GBP346,000) with cash at bank of GBP112,000 (2014: GBP106,000). Based on the current forecast, the Company is likely to need additional funds within twelve months of the date of approval of this Annual Report in order to maintain its proposed work programme and levels of expenditure.

Since the year end, the directors have sourced an investment proposal which they believe meets the Investment criteria as prescribed by the AIM rules. However this proposal is subject to both shareholder and approval from the AIM regulation team.

For this reason, the Directors continue to adopt the going concern basis in preparing the financial statements. Whilst there are inherent uncertainties in relation to future events, and therefore no certainty over the outcome of the matters described, the Directors consider that, based upon financial projections and dependent on the success of their efforts to complete these activities, the Company will be a going concern for the next twelve months. If it is not possible for the Directors to realise their plans, over which there is significant uncertainty, the carrying value of the assets of the Company is likely to be impaired.

Statement of Compliance

The following new and revised Standards and Interpretations have been adopted in the current period by the Company for the first time and do not have a material impact on the Company.

 
  IFRS 10     Consolidated financial 
               statements 
  IFRS 12     Disclosures of interests 
               in other entities 
 

A number of new standards and amendments to standards and interpretations have been issued but are not yet effective and not early adopted. None of these are expected to have a significant effect on the financial statements of the Company.

Segmental reporting

The Company does not have separately identifiable business or geographical segments which are material to disclose.

Revenue recognition

All revenue is stated net of the amount of sales tax. Currently the Company does not generate any revenue.

Presentational and functional currency

This financial information is presented in pounds sterling, which is the Company's functional currency.

Financial assets

Financial assets comprise investments, cash and cash equivalents and receivables. Unless otherwise indicated, the carrying amounts of the Company's financial assets are a reasonable approximation of their fair values.

Investments available for sale

Available for sale investments are recognised on a trade date where a purchase of an investment takes place.

Investments are measured at fair value in the balance sheet with finance income recognised in the Statement of Comprehensive Income on an effective interest rate basis.

Trade and other receivables

Provision for impairment of trade receivables is made when there is objective evidence that the Company will not be able to collect all amounts due to it in accordance with the original terms of those receivables. The amount of the write-down is the difference between the receivables carrying amount and the present value of the estimated future cash flows.

An assessment for impairment is undertaken at least annually.

Cash and cash equivalents

Cash and cash equivalents comprise cash at bank and in hand, demand deposits and other short term highly liquid investments that are readily convertible to a known amount of cash and are subject to insignificant risk of changes in value.

Financial liabilities

Financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument. Financial liabilities comprise only trade and other payables.

All financial liabilities are recorded at amortised cost, using the effective interest method, with interest-related charges being recognised as an expense under finance costs in the Income Statement. A financial liability is derecognised only when the obligation is extinguished, that is, when the obligation is discharged, is cancelled, or expires.

Finance costs

Finance costs of debt, including premiums payable on settlement and direct issue costs are charged to the income statement on an accruals basis over the term of the instrument, using the effective interest method.

The taxation charge represents the sum of current tax and deferred tax.

Income taxation

The tax payable is based on the taxable profit for the period using the tax rates that have been enacted or substantially enacted by the balance sheet date. Taxable profit differs from the net profit as reported in the income statement because

it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible.

Deferred taxation

Deferred tax is recognised, using the liability method, in respect of temporary differences between the carrying amount of the Company's assets and liabilities and their tax base. Deferred tax liabilities are offset against deferred tax assets within the same taxable entity. Any remaining deferred tax asset is recognised only when, on the basis of all available evidence, it can be regarded as probable that there will be suitable taxable profits in the foreseeable future against which the deductible temporary difference can be utilised. Deferred tax is determined using tax rates that are expected to apply in the periods in which the asset is realised or liability settled, based on tax rates and laws that have been enacted or substantially enacted by the balance sheet date. Deferred tax is recognised in the income statement, except when the tax relates to items charged or credited directly in equity, in which case the tax is also recognised in equity.

Share capital

Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as deduction, net of tax, from the proceeds.

Impairment

The carrying amounts of non-current assets are reviewed for impairment if events or changes in circumstances indicate the carrying value may not be recoverable. If there are indicators of impairment, an exercise is undertaken to determine whether the carrying values are in excess of their recoverable amount. Such a review is undertaken on an asset by asset basis, except where such assets do not generate cash flows independent of other assets, in which case the review is undertaken at the cash generating unit level. If the carrying amount of an asset or its cash generating unit exceeds the recoverable amount, a provision is recorded to reflect the asset or cash generating unit at the lower amount.

Foreign currency

Transactions entered into by by the Company in a currency other than the currency of the primary economic environment in which it operates (the "functional currency") are recorded at the rates ruling when the transactions occur. Foreign currency monetary assets and liabilities are translated at the rates ruling at the balance sheet date and the gains and losses on translation are included in the statement of profit or loss.

Critical accounting estimates and areas of judgement

The Company makes estimates and assumptions concerning the future, which by definition will seldom result in actual results that match the accounting estimate. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities within the next financial year are those in relation to investments.

   3.            Staff costs 
 
                                         2015      2014 
                                      GBP'000   GBP'000 
                      -----------------------  -------- 
 
 Wages and salaries                       107        49 
                      -----------------------  -------- 
 

The average number of employees and directors during the year was as follows:

 
                   2015   2014 
                  -----  ----- 
 
 Administration       2      6 
                  -----  ----- 
 
   4.            Directors' remuneration 

The aggregate directors' emoluments, including compensation for loss of office, in the year were:

 
                  2015      2014 
               GBP'000   GBP'000 
              --------  -------- 
 
 Emoluments        107        38 
              --------  -------- 
 

The highest paid director received remuneration of GBP50,664 (2014: GBP10,337).

   5.            Exceptional item 

During the year the Company fully impaired its investment in a subsidiary. Please see note 12 for movement in investments in the year.

 
                                                  2015       2014 
                                               GBP'000    GBP'000 
                                             ---------  --------- 
 
 Impairment of investment                            -   (12,294) 
 Provision against intra group payables              -        515 
 Provision against intra group receivables           -       (27) 
                                             ---------  --------- 
                                                     -   (11,806) 
 -----------------------------------------------------  --------- 
 
 
   6.            Administrative expenses 
 
                             2015      2014 
                          GBP'000   GBP'000 
                         --------  -------- 
 
 Staff costs                  107        49 
 Other expenses               333       182 
 Foreign exchange loss          -        26 
                         --------  -------- 
                              440       257 
                         --------  -------- 
 
   7.            Auditors' remuneration 
 
               2015   2014 
                GBP    GBP 
              -----  ----- 
 
 Audit fees      26     26 
              -----  ----- 
 
   8.            Investments - available for sale 
 
                          2015      2014 
                       GBP'000   GBP'000 
                      --------  -------- 
 
 Cash consideration        500         - 
 Origination fee*          107         - 
  Effective interest         8         - 
                      --------  -------- 
                           615         - 
                      --------  -------- 
 

On 30 October 2015 the Company entered into an agreement with Helix Investment Management SLP ("Helix") to originate securities, to provide and secure access to allocations of securities to be issued from time to time by Helix, and provide support to the executive management of the Company.

* - On November 2015, the Company subscribed for 50 units of the Tranche B Helix Securitisation Fund at an aggregate cost of GBP500,000. The Tranche B Helix Securitisation Fund notes yield 9.85% per annum. Under the terms of the agreement, 10 warrants representing 42,500,000 Warrant Shares in the Company were issued to Helix, and this has been accounted for as an origination fee. At the date of grant the warrants were valued using the Black-Scholes option pricing model.

On 24 June 2016 all warrant programs and issued warrants were cancelled by agreement with relevant parties. The Company has no outstanding warrants.

The fair value per warrant share granted and the assumptions used in the calculation were as follows:

 
 Date of grant                10 November 2015 
 Share price at grant date          GBP0.00375 
 Warrant exercise price              GBP0.0030 
 Expected volatility                    114.1% 
 Expected life                         3 years 
 Risk-free interest rate                 1.14% 
 Expected dividend yield                    0% 
 Fair value per warrant             GBP0.00253 
 
   9.            Trade and other receivables 
 
                         2015      2014 
                      GBP'000   GBP'000 
                     --------  -------- 
 Current 
 Other receivables          2         2 
                     --------  -------- 
 
 
   10.          Cash and cash equivalents 

Cash and cash equivalents include the following for the purposes of the cash flow statement:

 
                                2015      2014 
                             GBP'000   GBP'000 
                            --------  -------- 
 
 Cash at bank and in hand        112       106 
                            --------  -------- 
 
 
   11.          Trade and other payables 
 
                                    2015      2014 
                                 GBP'000   GBP'000 
                                --------  -------- 
 
 Trade and other payables              3       218 
 Accruals and deferred income         60        34 
 Other payables                       48       163 
                                --------  -------- 
                                     111       415 
                                --------  -------- 
 
 
   12.          Investment in subsidiary 
 
                                 2015       2014 
                              GBP'000    GBP'000 
                            ---------  --------- 
 
 At 1 January                       -     12,294 
 Impairment of investment           -   (12,294) 
                            ---------  --------- 
 At 31 December                     -          - 
                            ---------  --------- 
 

On 23 December 2014 the Company agreed to dispose of its 100% holding in Win Yu International Investments Limited. See Note 18 for further details.

   13.          Loss per share 
 
 The basic loss per share is calculated by dividing 
  the loss attributable to equity shareholders by the 
  weighted average number of shares in issue. 
 
  The loss attributable to equity shareholders and weighted 
  average number of ordinary shares for the purposes 
  of calculating diluted earnings per ordinary share 
  are identical to those used for basic earnings per 
  ordinary share. This is because the exercise of warrants 
  would have the effect of reducing the loss per ordinary 
  share and is therefore anti-dilutive. 
                                                2015           2014 
                                                 GBP            GBP 
                                        ------------  ------------- 
 
 Net loss for the year attributable 
  to ordinary shareholders                 (432,000)   (12,188,000) 
                                        ------------  ------------- 
 
 Weighted average number of shares in 
  issue                                  177,320,048     60,036,263 
                                        ------------  ------------- 
 
 Basic and diluted loss per share           (0.0024)       (0.2030) 
                                        ------------  ------------- 
 
   14.          Share capital 
 
                                                2015         2014 
                                                  No           No 
                                       -------------  ----------- 
 Issued and fully paid 
 Ordinary shares of GBP0.025 each                  -   60,036,263 
  Ordinary shares of no par value        427,175,955            - 
  Deferred shares of GBP0.0249 each       60,036,263            - 
 
 
                                                2015         2014 
                                                 GBP          GBP 
 Ordinary shares of GBP0.025 each                  -    1,500,907 
  Ordinary shares of of no par value               -            - 
  Deferred shares of GBP0.0249 each        1,494,903            - 
                                       -------------  ----------- 
                                           1,494,903    1,500,907 
 
 

On 9 January 2015 the Company undertook a share capital sub-division whereby each existing ordinary share of GBP0.025 each was subdivided into one new ordinary share of GBP0.0001 and one deferred share of GBP0.0249.

On 23 January 2015 the Company raised GBP225,000 by way of an issue of 78,071,429 new ordinary shares of GBP0.0001 each at 0.14p per share, and the issue of GBP115,700 nominal value convertible loan notes, exercisable at the Placing Price for 3 years from the date of issue.

On this date, the Company also agreed to issue 28,266,344 new ordinary shares to the holders of the GBP50,000 nominal value loan notes announced on 23 December 2014 who have served a conversion notice for their entire holding of convertible loan notes and a further 30,266,344 ordinary shares to Wonder Employee Capital Limited in full satisfaction of amounts owed to them, totalling GBP125,000.

On 5 March 2015 the ordinary shares of 0.01p each were amended to ordinary shares of no par value.

On 15 May 2015 the Company raised GBP100,000 by way of an issue of 11,494,252 new ordinary shares of no par value at a price of 0.87p per share.

On 12 June 2015 the Company raised GBP120,000 by way of an issue of 13,793,103 new ordinary shares of no par value at a price of 0.87p per share.

On 10 July 2015 the Company raised GBP100,000 by way of an issue of 11,494,252 new ordinary shares of no par value at a price of 0.87p per share.

On 6 August 2015 the Company raised GBP100,000 by way of an issue of 11,111,111 new ordinary shares of no par value at a price of 0.90p per share.

On 18 November the Company issued 82,642,857 new ordinary shares for settlement of the outstanding amount relating to the Convertible Loan Note of GBP115,700 together with accrued interest to date. See Note 15 for further details.

   15.          Convertible loan notes 
 
                              2015      2014 
                           GBP'000   GBP'000 
                         ---------  -------- 
 
 Convertible loan note           -        39 
                         ---------  -------- 
 
 

In January 2015, the Company entered into a convertible loan note agreement for GBP115,700. The interest rate on the loan was 10% per annum.

On 18 November 2015, the loan notes were fully converted into 82,642,857 new ordinary shares of no par value.

The convertible loan recognised on inception were calculated as follows:

 
                                                  2015      2014 
                                               GBP'000   GBP'000 
                                              --------  -------- 
 
 Nominal value of convertible loan note 
  issued                                           116        50 
 Equity component                                 (30)      (11) 
                                              --------  -------- 
 Liability component on initial recognition         86        39 
                                              --------  -------- 
 
   16.          Financial instruments 

Capital Risk Management

The Company's objectives when managing capital are:

-- to safeguard the Company's ability to continue as a going concern, so that it continues to provide returns and benefits for shareholders;

   --     to support the Company's growth; and 
   --     to provide capital for the purpose of strengthening the Company's risk management capability 

The Company actively and regularly reviews and manages its capital structure to ensure an optimal capital structure and equity holder returns, taking into consideration the future capital requirements of the Company and capital efficiency, prevailing and projected profitability, projected operating cash flows, projected capital expenditures and projected strategic investment opportunities. Management regards total equity as capital and reserves, for capital management purposes.

Risk Management Objectives and Policies

The Company is exposed to a variety of financial risks which result from both its operating and investing activities. The Company's risk management is coordinated by the board of directors, and focuses on actively securing the Company's short to medium term cash flows by minimising the exposure to financial markets.

Market Price Risk

The Company's exposure to market price risk mainly arises from potential movements in the fair value of its investments. The Company manages this price risk within its long-term investment strategy to manage a diversified exposure to the market. If each of the Company's equity investments were to experience a rise or fall of 10% in their fair value, this would result in the Company's net asset value and statement of comprehensive income increasing or decreasing by GBP61,500 ( 2014: GBPnil).

Foreign Currency Risk

The Company's exposure to foreign currencies is limited to its investments which are quoted on overseas stock markets in currencies other than Pounds Sterling and is not material.

Credit Risk

The Company's financial instruments, which are exposed to credit risk, are considered to be mainly cash and cash equivalents and the Company's receivables are not material. The credit risk for cash and cash equivalents is not considered material since the counterparties are reputable banks.

The Company's exposure to credit risk is limited to the carrying amount of the financial assets recognised at the balance sheet date, as summarised below:

 
                                  2015       2014 
                               GBP'000    GBP'000 
                             ---------  --------- 
 Cash and cash equivalents         112        106 
 Other receivables                   2          2 
                             ---------  --------- 
                                   114        108 
                             ---------  --------- 
 

Liquidity Risk

Liquidity risk is managed by means of ensuring sufficient cash and cash equivalents are held to meet the Company's payment obligations arising from administrative expenses.

Financial Instruments

The Company's financial instruments comprise borrowings, cash and various items, such as trade receivables and trade payables that arise directly from its operations. The main purpose of these financial instruments is to raise finance for the Company's operations.

The main risks arising from its financial instruments are interest rate, liquidity, foreign currency and credit risk. The board reviews and agrees policies for managing each of these risks and they are summarised below together with a sensitivity analysis. These policies have remained unchanged from previous years.

Interest rate risk

The Company finances its operations through a mixture of loans and equity capital. Borrowings are generally at floating rates of interest. The Company does not enter into any interest rate derivative transactions to manage interest rate risk. The Company had no interest bearing loans at the year-end or the prior period end and hence no interest rate exposure.

Liquidity risk

The Company seeks to manage financial risk by ensuring liquidity is available to meet foreseeable needs and by investing cash assets safely and profitably.

As at 31 December 2015 the Company's liabilities have contractual maturities which are summarised below:

 
31 December 2015                Current            Non-current 
                              Within  6 to 12   1 to 5  later than 
                            6 months   months    years     5 years 
                             GBP'000  GBP'000  GBP'000     GBP'000 
                           ---------  -------  -------  ---------- 
Convertible Loan note              -        -        -           - 
Trade and other payables         111        -        -           - 
                           ---------  -------  -------  ---------- 
                                 111        -        -           - 
                           =========  =======  =======  ========== 
 

This compares to the maturity of the Company's financial liabilities in the previous reporting period as follows:

 
31 December 2014                Current            Non-current 
                              Within  6 to 12   1 to 5  later than 
                            6 months   months    years     5 years 
                             GBP'000  GBP'000  GBP'000     GBP'000 
                           ---------  -------  -------  ---------- 
Convertible loan note              -       39        -           - 
Trade and other payables         290        -        -           - 
                           ---------  -------  -------  ---------- 
                                 290       39        -           - 
                           =========  =======  =======  ========== 
 

Credit risk

The Company's exposure to credit risk is limited to the carrying amounts of financial assets recognised at the balance sheet date, as follows:

 
                                  2015            2014 
                               GBP'000         GBP'000 
                               -------  -------------- 
Trade and other receivables        111             290 
Cash and cash equivalents          112             106 
                               -------  -------------- 
                                   223             396 
                               =======  ============== 
 

The key management of the Company continuously monitor defaults of customers and other counterparties, identified either individually, or by group, and incorporates this information into its credit controls. Where available at reasonable cost external credit ratings and/or reports on customers and other counter parties are obtained and used. The Company's policy is to deal only with creditworthy counterparties.

The Company's management considers that all the above financial assets that are not impaired for each of the reporting dates under review are of good credit quality, including those that are past due.

None of the Company's financial assets are secured by collateral or other credit enhancements.

In respect of trade and other receivables, the Company is not exposed to any significant credit risk exposure to any counterparties having similar characteristics. The credit risk for liquid funds and other short-term financial assets is considered negligible, since the counterparties are reputable banks with high quality external credit ratings.

Financial instruments measured at fair value

The Company adopted the amendments to IFRS 7 Improving Disclosures about Financial Instruments effective from 1 January 2009. These amendments require the Company to present certain information about financial instruments measured at fair value in the statement of financial position specifically the fair value hierarchy. The fair value hierarchy Company's financial assets and liabilities into three levels based on the significance of inputs used in

measuring the fair values of the financial assets and liabilities. The fair value hierarchy has the following levels; Level 1 - quoted prices (unadjusted) in active markets for identical assets or liabilities; Level 2 - inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices) and Level 3 - inputs for the asset or liability that are not based on observable market data (unobservable inputs). No financial assets or liabilities are measured at fair value in the statement of financial position.

Categories of financial instruments

The carrying amounts of the Company's financial assets and liabilities as recognised at the balance sheet date of the reporting periods under review may also be categorised as follows:

 
                                     2015     2014 
                                  GBP'000  GBP'000 
                                  -------  ------- 
Financial assets: 
Investments held at fair value 
 through profit or loss               615        - 
Cash and bank balances                112      106 
Loans and receivables                   2        2 
                                  -------  ------- 
                                      729      108 
                                  =======  ======= 
 
 
Financial liabilities at amortised 
 cost: 
Trade and other payables              111  290 
                                      ---  --- 
                                      111  290 
                                      ===  === 
 
   17.          Reserves 

The following describes the nature and purpose of each reserve:

 
 Share Capital       represents the nominal value of equity 
                      shares 
 Share Premium       amount subscribed for share capital 
                      in excess of the nominal value 
 Retained Earnings   cumulative net gains and losses less 
                      distributions made 
 
   18.          Discontinued Operations 

On 23 December 2014, the Company agreed to dispose of its operating subsidiary -Jiangsu Qihang CCNC Machinery Tools CO. Ltd ("JSQH") back to its original owners.

Under the terms of the agreement approved by the shareholders on 9 January 2015, the purchasers agreed to acquire the entire issued share capital of Win Yu International Investments Company Limited ("Win Yu"), which held 100%. of JSQH and assume all of the operational debt of JSQH. In additional consideration for the transaction, the purchasers also transferred Purchaser shares they currently held back to the company.

The major classes of assets and liabilities comprising the disposal group and classified as held for sale are as follows:

 
                                      2015     2014 
                                   GBP'000  GBP'000 
                                   -------  ------- 
Financial assets at amortised 
 cost 
 
Goodwill                                 -    3,841 
Property, plant and equipment            -   17,101 
Inventories                              -    8,803 
Trade and other receivables              -    4,363 
Cash and bank balances                   -    4,022 
Total assets classified as held 
 for sale                                -   38,130 
                                   -------  ------- 
 
 
Financial liabilities at amortised 
 cost: 
 
Trade and other payables              -14,248 
Borrowings                            -19,842 
                                       ------ 
Total liabilities associated 
 with assets classified as held 
 for sale                             -34,090 
                                       ------ 
 
Net assets of disposal group          - 4,040 
                                       ====== 
 

During the year discontinued operations used net cash of GBP404,000 (2014: GBP901,000) in operating activities, paid GBP42,000 (2014: GBP413,000) in respect of investing activities, and paid GBPnil (2014: GBPnil) in respect of financing activities.

   19.          Related Party Transactions 

Gregory Collier was paid fees of GBP50,664 in the year as per the terms of his consultancy agreement with the Company.

Stuart Black was paid fees of GBP40,000 in the year as per the terms of his consultancy agreement with the Company

Andrew Oswald was paid fees of GBP16,664 under the terms of his consultancy agreement with the Company.

   20.          Capital Commitments and Contingent Liabilities 

At the balance sheet date, the Company had no known contingent liabilities and capital commitments other than those shown in the financial statements.

   21.          Post Year End Events 

On 11 January 2016 the directors of Eastbridge announced that they have agreed terms for the acquisition of Privilege Wealth Plc ("Privilege").

On 11 January 2016 the Company announced the temporary suspension of trading on AIM.

On 21 June 2016, the directors announced that they had terminated their negotiations to acquire "Privilege" but were pursuing an alternative investment plan.

   22.          Ultimate Controlling Party 

There was no single controlling party.

For further additional information please contact:

 
 Eastbridge Investments Plc          Tel: +44 (0)78 
  Gregory Collier                     301 82501 
 Nominated Adviser                   Tel: +44 (0)20 
  Northland Capital Partners          3861 6625 
  Limited 
  William Vandyk / Matthew Johnson 
 Broker                              Tel: +44 (0)20 
  Peterhouse Corporate Finance        7469 0930 
  Limited 
  Fungai Ndoro /Lucy Williams 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

FR URRBRNUANORR

(END) Dow Jones Newswires

June 30, 2016 03:03 ET (07:03 GMT)

Eastbridge Inv (LSE:EBIV)
過去 株価チャート
から 5 2024 まで 6 2024 Eastbridge Invのチャートをもっと見るにはこちらをクリック
Eastbridge Inv (LSE:EBIV)
過去 株価チャート
から 6 2023 まで 6 2024 Eastbridge Invのチャートをもっと見るにはこちらをクリック